116 related articles for article (PubMed ID: 38860864)
1. Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients.
Somay E; Topkan E; Bascil S; Kılıc Durankuş N; Senyürek Ş; Ozturk D; Pehlivan B; Selek U
Biomol Biomed; 2024 Jun; ():. PubMed ID: 38860864
[TBL] [Abstract][Full Text] [Related]
2. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.
Somay E; Yilmaz B; Topkan E; Ozdemir BS; Ozturk D; Besen AA; Mertsoylu H; Selek U
Int J Biol Markers; 2024 Mar; 39(1):80-88. PubMed ID: 38192114
[TBL] [Abstract][Full Text] [Related]
3. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.
Somay E; Topkan E; Pehlivan UA; Yilmaz B; Besen AA; Mertsoylu H; Pehlivan B; Selek U
Tomography; 2024 Jan; 10(1):79-89. PubMed ID: 38250953
[TBL] [Abstract][Full Text] [Related]
4. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
Topkan E; Somay E; Yilmaz B; Pehlivan B; Selek U
BMC Cancer; 2023 Jul; 23(1):651. PubMed ID: 37438683
[TBL] [Abstract][Full Text] [Related]
5. Low hemoglobin levels predict increased radiation-induced trismus rates in nasopharyngeal cancer.
Somay E; Yilmaz B; Topkan E; Pehlivan B; Selek U
Oral Dis; 2024 Apr; 30(3):1052-1060. PubMed ID: 37154238
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin-to-platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy.
Somay E; Yilmaz B; Topkan E; Kucuk A; Haksoyler V; Pehlivan B; Selek U; Araz K
Oral Dis; 2023 Oct; 29(7):2962-2970. PubMed ID: 36038508
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy.
Topkan E; Selek U; Pehlivan B; Kucuk A; Ozturk D; Ozdemir BS; Besen AA; Mertsoylu H
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760482
[TBL] [Abstract][Full Text] [Related]
8. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
Somay E; Topkan E; Kucuk A; Ozturk D; Ozkan EE; Ozdemir BS; Besen AA; Mertsoylu H; Pehlivan B; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101838. PubMed ID: 38518893
[TBL] [Abstract][Full Text] [Related]
9. The predictive usefulness of the novel "combined hemoglobin-to-platelet ratio and maximum mouth opening index" on prevalence of radiation induced trismus in patients with nasopharyngeal cancer.
Somay E; Yilmaz B; Topkan E; Kucuk A; Pehlivan B; Selek U
Head Neck; 2023 Jul; 45(7):1823-1831. PubMed ID: 37173823
[TBL] [Abstract][Full Text] [Related]
10. Initial neutrophil-to-lymphocyte ratio predicts radiation-induced trismus in parotid gland cancer.
Somay E; Yilmaz B; Topkan E; Kucuk A; Pehlivan B; Selek U
Oral Dis; 2023 Oct; 29(7):2772-2779. PubMed ID: 36349491
[TBL] [Abstract][Full Text] [Related]
11. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas.
Yilmaz B; Somay E; Topkan E; Pehlivan B; Besen AA; Mertsoylu H; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jan; 125(6):101786. PubMed ID: 38286220
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
13. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
Strahlenther Onkol; 2023 Oct; 199(10):910-921. PubMed ID: 37566126
[TBL] [Abstract][Full Text] [Related]
14. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
Mané M; Benkhaled S; Dragan T; Paesmans M; Beauvois S; Lalami Y; Szturz P; Gaye PM; Vermorken JB; Van Gestel D
Oncologist; 2021 Jan; 26(1):e130-e141. PubMed ID: 32924198
[TBL] [Abstract][Full Text] [Related]
16. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.
Yilmaz B; Somay E; Topkan E; Pehlivan B; Selek U
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2575-2584. PubMed ID: 36749372
[TBL] [Abstract][Full Text] [Related]
17. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
[No Abstract] [Full Text] [Related]
18. Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma.
Zhang J; Peng H; Li WF; Zhang Y; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
BMC Cancer; 2018 Dec; 18(1):1276. PubMed ID: 30567511
[TBL] [Abstract][Full Text] [Related]
19. Postchemoradiotherapy systemic inflammation response index predicts treatment response and overall survival for patients with locally advanced nasopharyngeal cancer.
Lu YF; Wu CY; Lo WC; Chiu YL; Shueng PW; Hsieh CH; Hsu CX; Kuo DY; Hou PY; Liao LJ
J Formos Med Assoc; 2023 Nov; 122(11):1141-1149. PubMed ID: 37202235
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]